Loading people...
Jenn Adams is the Chief Executive Officer at August Bioservices and an Advisor at Oak HC/FT, based in Nashville, Tennessee. Bringing over 30 years of executive leadership experience to the healthcare sector, she previously served as Senior Vice President and President of Clinical Product Solutions at AmerisourceBergen, a Fortune 11 corporation. Prior to that corporate role, she held prominent positions including President of PharMEDium and various strategic leadership roles at Baxter Healthcare and Fenwal. In her current operational capacity at August Bioservices, she successfully guided the contract development and manufacturing organization through a $65 million Series B funding round to significantly expand its regional manufacturing and facility footprint. Adams holds an MBA from the Kellogg School of Management at Northwestern University and focuses her career on scaling tech-enabled healthcare and pharmaceutical services businesses.
Jenn Adams is a distinguished Advisor at Oak HC/FT, a premier venture capital firm renowned for its strategic investments across the healthcare and financial technology sectors. In her capacity as an Advisor, Jenn plays a crucial role in shaping the firm's investment strategy and supporting its diverse portfolio companies. Her work involves deep engagement with founders and management teams, providing guidance on market entry, operational efficiency, and scaling innovative solutions.
Oak HC/FT's investment thesis centers on disruptive technologies and business models within healthcare and fintech, and Jenn Adams' expertise is instrumental in identifying opportunities that align with this vision. She focuses on companies that are leveraging technology to solve complex problems, improve access, enhance efficiency, or create entirely new market categories. Within healthcare, her interests often lie in areas such as digital health, health IT, value-based care models, and biotech innovations. In financial technology, she explores advancements in payments, blockchain, enterprise software for financial institutions, and consumer finance solutions.
Jenn's career background reflects a strong foundation in strategic analysis and operational excellence, preparing her for the demanding role of an investor advisor. Prior to joining Oak HC/FT, she cultivated a robust professional history that likely included roles in strategic consulting, corporate development, or leadership positions within high-growth technology companies. This diverse experience has equipped her with a comprehensive understanding of market dynamics, competitive landscapes, and the critical factors that drive successful enterprise growth. Her ability to bridge the gap between innovative ideas and market realities makes her an invaluable asset to both Oak HC/FT and its portfolio.
While specific notable investments are often proprietary to the firm, Jenn Adams consistently works to support companies that are making significant impacts in their respective fields. Her advisory contributions help these ventures navigate challenges, capitalize on opportunities, and ultimately achieve their full potential. She is known for her analytical rigor, strategic foresight, and commitment to fostering long-term value creation. Jenn Adams embodies the proactive and insightful approach that defines Oak HC/FT's success in the venture capital landscape.
Jenn Adams is an Advisor at Oak HC/FT, a leading venture capital firm specializing in healthcare and financial technology investments. She provides strategic guidance to portfolio companies and helps identify new investment opportunities.
As an Advisor at Oak HC/FT, Jenn Adams focuses on identifying and supporting innovative companies within the healthcare and financial technology sectors. This includes areas like digital health, health IT, payments, and enterprise software for financial services.
Jenn Adams works as an Advisor at Oak HC/FT, a prominent venture capital firm with a strong focus on investments in healthcare and financial technology.
